2020 Virtual MS Connect Conference
Every year, the MS Connect Conference allows people affected by multiple sclerosis (MS) to engage with leading Canadian investigators and learn about recent…
Experts share latest updates on MS research at MSVirtual2020 (joint ACTRIMS/ECTRIMS conference)
Scientists, clinicians and health care professionals from around the world gathered virtually on September 11-13 to participate in the 8th ACTRIMS (Americas Committee…
Bringing Together a Community of Researchers – 2019 endMS Conference
On December 8-11, 2019 in Calgary, Alberta, the MS Society of Canada held the 2019 endMS Conference to bring together multiple sclerosis (MS)…
Latest news from the European Committee for Treatment and Research in Multiple Sclerosis 2019
On September 11-13, 2019, the European Committee for Treatment and Research in Multiple Sclerosis (a conference known as ECTRIMS) held their 35th Congress…
ACTRIMS Forum 2019 and its focus on precision Medicine in MS
The theme of the #ACTRIMS Forum 2019 was “Precision Medicine Approaches for MS: Scientific Principles to Clinical Application.” Many talks and presentations were…
Cutting Edge Developments: Treatment in development, technology-based clinical measures, and predicting progression in MS
Presenters at the cutting-edge developments in MS session at #ACTRIMS deliver the latest key findings on pivotal studies. At the session, we heard…
Emerging Concepts in MS: MRI measure as an indicator of potential conversion to SPMS, novel therapeutic targets of neuroinflammation, and roles of biological measures of aging in MS
Presenters at the emerging concepts in MS session at the ACTRIMS 2019 Forum deliver results on novel research areas in MS. At the…
Leading researchers to present on MS discoveries at the fourth annual ACTRIMS Forum 2019
The research team will be attending the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum 2019. We are excited to…
ECTRIMS 2018: Catching up with the MS-Society funded collaborative team that is working to improve cognition in people with progressive MS
The Multiple Sclerosis Society of Canada announced last month a $5 million grant in support of the first, international, multicenter clinical trial to investigate cognitive…
